Biopharma M&A Q1 2026: Deal Tracker and AI Valuations
Analyze Q1 2026 biopharma M&A trends, including 19 billion-dollar deals. Learn how patent cliffs and AI valuation drivers impact pharmaceutical acquisitions.
IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.
Analyze Q1 2026 biopharma M&A trends, including 19 billion-dollar deals. Learn how patent cliffs and AI valuation drivers impact pharmaceutical acquisitions.

Review the $12B wave of Q1 2026 oncology AI deals and pharma M&A. This analysis explains how patent cliffs, CAR-T, and AI drug discovery drive acquisitions.
© 2026 IntuitionLabs. All rights reserved.